Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | MCOLN2 | Q8IZK6 | 2/20 | 0.47 |
| ▸ | MCOLN3 | Q8TDD5 | 2/20 | 0.47 |
| ▸ | MCOLN1 | Q9GZU1 | 2/20 | 0.47 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.47 |
| ▸ | PSEN2 | P49810 | 2/20 | 0.47 |
| ▸ | APH1B | Q8WW43 | 2/20 | 0.47 |
| ▸ | NCSTN | Q92542 | 2/20 | 0.47 |
| ▸ | APH1A | Q96BI3 | 2/20 | 0.47 |
| ▸ | PSENEN | Q9NZ42 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL419813 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E | |
| SCHEMBL6816353 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E | |
| SCHEMBL987578 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E | |
| P-Xylene SCHEMBL5422459 | 0.98 | ALDH1A1 (0.60) | ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E | |
| P-Xylene SCHEMBL5421280 | 0.98 | ALDH1A1 (0.60) | ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E | |
| SCHEMBL6055077 | 0.98 | ALDH1A1 (0.60) | ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E | |
| SCHEMBL3499611 | 0.97 | ALDH1A1 (0.58) | ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E | |
| Benzene SCHEMBL5180862 | 0.96 | ALDH1A1 (0.57) | ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E | |
| Hexamethylbenzene SCHEMBL5424696 | 0.96 | ALDH1A1 (0.57) | ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E | |
| Benzene SCHEMBL5181252 | 0.96 | ALDH1A1 (0.57) | ALDH1A1TSHRCYP3A4SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3856738-A1 | PROCESS FOR THE PREPARATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | Química Sintética, S.A. (ES) | 2021-08-04 | — | — | EP | claimed |
| WO-2020064818-A1 | PROCESS FOR THE PREPARATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | Química Sintética, S.A. (ES) | 2020-04-02 | — | — | WO | claimed |
| EP-2167505-B1 | PREPARATION OF N-ALKYLATED OPIATES BY REDUCTIVE AMINATION | MALLINCKRODT LLC (US) | 2012-11-28 | — | — | EP | claimed |
| US-7985858-B2 | Process for the preparation of 6-alpha-hydroxy-N-alkylated opiates | MALLINCKRODT INC. (US) | 2011-07-26 | — | — | US | claimed |
| EP-2152715-B1 | IMPROVED PROCESS FOR THE PREPARATION OF 6-ALPHA-HYDROXY-N-ALKYLATED OPIATES | MALLINCKRODT INC (US) | 2010-12-29 | — | — | EP | claimed |
| EP-2167505-A1 | PREPARATION OF N-ALKYLATED OPIATES BY REDUCTIVE AMINATION | Mallinckrodt Inc. (US) | 2010-03-31 | — | — | EP | claimed |
| US-20100041888-A1 | Process for the Preparation of 6-Alpha-Hydroxy-N-Alkylated Opiates | MALLINCKRODT ENTERPRISES LLC | 2010-02-18 | — | — | US | claimed |
| EP-2152715-A1 | IMPROVED PROCESS FOR THE PREPARATION OF 6-ALPHA-HYDROXY-N-ALKYLATED OPIATES | Mallinckrodt Inc. (US) | 2010-02-17 | — | — | EP | claimed |
| WO-2009012005-A1 | PREPARATION OF N-ALKYLATED OPIATES BY REDUCTIVE AMINATION | MALLINCKRODT INC. (US) | 2009-01-22 | — | — | WO | claimed |
| WO-2008137672-A1 | IMPROVED PROCESS FOR THE PREPARATION OF 6-ALPHA-HYDROXY-N-ALKYLATED OPIATES | MALLINCKRODT INC. (US) | 2008-11-13 | — | — | WO | claimed |
| CN-1550482-A | Process for manufacture of trans-(R,R)-actinol | DSM IP资产公司 | 2004-12-01 | — | — | CN | claimed |
| EP-0915076-B1 | Process for the preparation of trans-(R,R)-actinol | HOFFMANN LA ROCHE (CH) | 2002-01-16 | — | — | EP | claimed |
| US-6187961-B1 | HYDROGENATING (R)-LEVODIONE IN PRESENCE OF HYDROGEN DONAR AND A SOLVENT OR IN PRESENCE OF HYDROGEN DONOR WHICH SIMULTANEOUSLY USED AS THE SOLVENT, AND AN AMINO-AMIDE-RUTHENIUM COMPLEX | ROCHE VITAMINS INC. | 2001-02-13 | — | — | US | claimed |
| CN-1223998-A | Process for producing trans- (R, R) -actinol | HOFFMANN LA ROCHE (CH) | 1999-07-28 | — | — | CN | claimed |
| EP-0915076-A1 | Process for the preparation of trans-(R,R)-actinol | F. HOFFMANN-LA ROCHE AG (CH) | 1999-05-12 | — | — | EP | claimed |
| US-20230285945-A1 | CATALYST CONTAINING ACTIVATED CARBON ADSORBED WITH RUTHENIUM COMPLEX, AND METHOD FOR PRODUCING REDUCTION PRODUCT USING SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| EP-4115975-A1 | CATALYST CONTAINING ACTIVATED CARBON ON WHICH RUTHENIUM COMPLEX IS ADSORBED, AND METHOD FOR PRODUCING REDUCTION PRODUCT USING SAME | Takasago International Corporation (JP) | 2023-01-11 | — | — | EP | disclosed |
| EP-0915076-A1 | Process for the preparation of trans-(R,R)-actinol | F. HOFFMANN-LA ROCHE AG (CH) | 1999-05-12 | — | — | EP | disclosed |
| US-3936471-A | HYPOGLYCEMIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-02-03 | — | — | US | disclosed |
| US-3936471-A | HYPOGLYCEMIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230285945-A1 | CATALYST CONTAINING ACTIVATED CARBON ADSORBED WITH RUTHENIUM COMPLEX, AND METHOD FOR PRODUCING REDUCTION PRODUCT USING SAME | RRS1, POR, SCO2 | ALDH1A1 492/4885TSHR 4343/4885CYP3A4 59/4885 |
| US-20100041888-A1 | Process for the Preparation of 6-Alpha-Hydroxy-N-Alkylated Opiates | OPRM1, OPRK1, OPRD1 | ALDH1A1 449/4885TSHR 3294/4885CYP3A4 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.